Abstract:IL‐17A, the effector cytokine of T helper (Th) 17 cells, plays a crucial role in the pathogenesis of psoriasis. The Notch1 and PI3K/AKT signaling pathways are implicated in Th17 cell differentiation and IL‐17A production. The present study aimed to evaluate the regulatory effect of the Notch1/hairy and enhancer of split 1 (Hes1)‐PTEN/AKT/IL‐17A feedback loop on Th17 cell differentiation via the PI3K/AKT inhibitor LY294002 in a mouse model of psoriasis. Mice were randomly divided into 3 groups: a control group, a model group [5% imiquimod (IMQ)‐induced group] and an intervention group (5% IMQ‐induced plus LY294002‐treated group). Skin structural characteristics were recorded and evaluated by hematoxylin and eosin staining. The weights of the spleens and inguinal lymph nodes were measured. Th17 cell percentage, as well as the mRNA and protein expression levels of Notch1, Notch1 intracellular domain (NICD1), Hes1, PTEN, AKT, phosphorylated (p)‐AKT, mTOR complex 1 (mTORC1), p‐mTORC1, S6 kinase (S6K)1, S6K2 and IL‐17A were detected in skin samples of the three experimental groups. Additionally, splenic mononuclear cells from model mice were treated by 10 and 50 μM LY294002 to further evaluate its regulatory effect on Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop. Increased Th17 cell percentage, increased expression of Notch1, NICD1, Hes1, AKT, p‐AKT, mTORC1, p‐mTORC1, S6K1, S6K2 and IL‐17A, and decreased PTEN levels were observed in model mice alongside marked psoriasis‐like skin inflammation, splenomegaly and lymphadenopathy. LY294002 treatment significantly alleviated the severity of psoriasis‐like skin inflammation in the intervention mice, attenuated the degree of epidermal hyperplasia and dermal inflammatory cell infiltration, and mitigated splenomegaly and lymphadenopathy. In addition, LY294002 treatment reversed the increased Th17 cell percentage, as well as the increased expression of Notch1, NICD1, Hes1, AKT, p‐AKT, mTORC1, p‐mTORC1, S6K1, S6K2 and IL‐17A, and the decreased expression of PTEN. In vitro study from 5% IMQ‐induced mouse splenic mononuclear cells presented that high dose of LY294002 exerted more obviously regulatory effect on Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop. The current findings suggested that the Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop regulates Th17 cell differentiation within the disease environment of psoriasis. Blocking the Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop may thus be a potential therapeutic method for management of psoriatic inflammation.

Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease

IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation

Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice

Zdhhc2 Is Essential for Plasmacytoid Dendritic Cells Mediated Inflammatory Response in Psoriasis

IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Uncoupling melanogenesis from proliferation in epidermal melanocytes responding to stimulation with psoriasis-related proinflammatory cytokines

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis

Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton-Merten syndrome variant

Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation

IL22RA2 is a Smad7 target mediating alleviation of dermatitis and psoriatic phenotypes in mice

Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis

Profiles of Innate Immune Cell Infiltration and Related Core Genes in Psoriasis

The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis

Ifi204 As the Most Favored Candidate Gene That Regulates Susceptibility to Spontaneous Arthritis in Mice Deficient in IL-1ra

Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling

Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6

Targeting dendritic cell-specific TNFR2 improves skin and joint inflammation by inhibiting IL-12/ IFN-γ pathways in a mouse model of psoriatic arthritis.

Inhibition of eukaryotic translation initiation factor 1A (eIF1A) and 3B (eIF3B) diminishes the psoriatic phenotype in two mouse models and human 3D model samples

Notch1/Hes1‐PTEN/AKT/IL‐17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‐like skin inflammation